Quality of life and pharmacoeconomics in clinical trials

摘要: The Second Edition of this groundbreaking work refines the art and science quality life assessment pharmacoeconomics redefines role these evaluation parameters in clinical trials health care decision-making. Dr. Spilker has assembled more than 200 experts from diverse clinical, research, social disciplines to provide a comprehensive reference on methodology, interpretation, use pharmacoeconomic studies. Expanded four times its predecessor's size scope, features: all-new sections crucial policy issues such as outcomes research new, extensive section cross-cultural cross-national detailed information specific tests measures guidelines choosing administering analyzing, interpreting, presenting data many chapters new topics phenomenology, spiritual status, alternative/complementary medical treatments